U.S. stocks reacted positively following the Federal Open Market Committee’s announcement in mid-September that it would lower interest rates by 50 basis points, wider than many analysts had anticipated. Generally, a lower federal funds rate is often a boon for stocks, as businesses are able to more easily secure loans to facilitate growth and consumers…
European shares slipped on Friday after a rally in the previous session spurred by the U.S. Federal Reserve‘s outsized interest rate cut, while drugmaker Novo Nordisk slid on disappointing obesity pill data. The pan-European STOXX 600 index closed 1.4% lower, though it recorded a second straight week of gains. All major European stock markets had…
Merck & Co., Inc. NYSE: MRK is one of the largest pharmaceutical firms in the world. The firm ranks fourth behind giants like Eli Lilly NYSE: LLY and Novo Nordisk NYSE: NVO, with a market capitalization of $294 billion. The company’s forward price-to-earnings (P/E) ratio sits at 13x. Compared to a peer group of the…
LLY Eli Lilly and Company $951.00 -1.74 (-0.18%) (As of 10:46 AM ET) 52-Week Range $516.57 ▼ $972.53 Dividend Yield 0.55% P/E Ratio 140.06 Price Target $956.88 Eli Lilly and Co. NYSE: LLY is a pharmaceutical giant that’s made headlines for its GLP-1/GIP weight loss drug Tirzepatide, known as Mounjaro for type 2 diabetes, and Zepbound…
European shares closed higher on Thursday, boosted by banking, technology and healthcare stocks, though they finished below session highs after the European Central Bank cut lending rates for the first time since 2019 but left the timing of future moves unclear. The pan-European STOXX 600 closed 0.7% higher, off record high levels hit earlier in…